Literature DB >> 15542848

Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.

Chiaki Takahashi1, Bernardo Contreras, Roderick T Bronson, Massimo Loda, Mark E Ewen.   

Abstract

Although the retinoblastoma protein (pRb) has been implicated in the processes of cellular differentiation, there is no compelling genetic or in vivo evidence that such activities contribute to pRb-mediated tumor suppression. Motivated by cell culture studies suggesting that Ras is a downstream effector of pRb in the control of differentiation, we have examined the tumor and developmental phenotypes of Rb and K-ras double-knockout mice. We find that heterozygosity for K-ras (i) rescued a unique subset of developmental defects that characterize Rb-deficient embryos by affecting differentiation but not proliferation and (ii) significantly enhanced the degree of differentiation of pituitary adenocarcinomas arising in Rb heterozygotes, leading to their prolonged survival. These observations suggest that Rb and K-ras function together in vivo, in the contexts of both embryonic and tumor development, and that the ability to affect differentiation is a major facet of the tumor suppressor function of pRb.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542848      PMCID: PMC529028          DOI: 10.1128/MCB.24.23.10406-10415.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Retinoblastoma protein is functionally distinct from its homologues in affecting glucocorticoid receptor-mediated transcription and apoptosis.

Authors:  P Singh; S W Chan; W Hong
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

2.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.

Authors:  D M Thomas; S A Carty; D M Piscopo; J S Lee; W F Wang; W C Forrester; P W Hinds
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

3.  Opposing roles of pRB and p107 in adipocyte differentiation.

Authors:  M Classon; B K Kennedy; R Mulloy; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.

Authors:  Harold I Saavedra; Lizhao Wu; Alain de Bruin; Cynthia Timmers; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Cell Growth Differ       Date:  2002-05

5.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.

Authors:  U Ziebold; T Reza; A Caron; J A Lees
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

7.  Deregulated MAPK activity prevents adipocyte differentiation of fibroblasts lacking the retinoblastoma protein.

Authors:  Jacob B Hansen; Rasmus K Petersen; Claus Jørgensen; Karsten Kristiansen
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

8.  Retinoblastoma protein complexes with C/EBP proteins and activates C/EBP-mediated transcription.

Authors:  A Charles; X Tang; E Crouch; J S Brody; Z X Xiao
Journal:  J Cell Biochem       Date:  2001 Aug 21-Sep 5       Impact factor: 4.429

9.  The retinoblastoma protein is linked to the activation of Ras.

Authors:  K Y Lee; M H Ladha; C McMahon; M E Ewen
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 10.  Disruption of differentiation in human cancer: AML shows the way.

Authors:  Daniel G Tenen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

View more
  19 in total

1.  MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras.

Authors:  Jun Liu; Xiao-Ju Luo; An-Wen Xiong; Zeng-di Zhang; Shen Yue; Ming-Sheng Zhu; Steven Y Cheng
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.

Authors:  Frederick Bauzon; Liang Zhu
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

3.  Wild-type NRas and KRas perform distinct functions during transformation.

Authors:  Poppy P Fotiadou; Chiaki Takahashi; Hasan N Rajabi; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

4.  ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Authors:  Awad Shamma; Misa Suzuki; Naoyuki Hayashi; Masahiko Kobayashi; Nobunari Sasaki; Takumi Nishiuchi; Yuichiro Doki; Takahiro Okamoto; Susumu Kohno; Hayato Muranaka; Shunsuke Kitajima; Ken-Ichi Yamamoto; Chiaki Takahashi
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

5.  p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior.

Authors:  Z Ma; Z Liu; R-F Wu; L S Terada
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 6.  The retinoblastoma tumor-suppressor gene, the exception that proves the rule.

Authors:  D W Goodrich
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

7.  lin-35/Rb and the CoREST ortholog spr-1 coordinately regulate vulval morphogenesis and gonad development in C. elegans.

Authors:  Aaron M Bender; Natalia V Kirienko; Sara K Olson; Jeffery D Esko; David S Fay
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

8.  Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice.

Authors:  Hongbo Wang; Frederick Bauzon; Peng Ji; Xiaoliang Xu; Daqian Sun; Joseph Locker; Rani S Sellers; Keiko Nakayama; Keiich I Nakayama; David Cobrinik; Liang Zhu
Journal:  Nat Genet       Date:  2009-12-06       Impact factor: 38.330

9.  Perturbation biology: inferring signaling networks in cellular systems.

Authors:  Evan J Molinelli; Anil Korkut; Weiqing Wang; Martin L Miller; Nicholas P Gauthier; Xiaohong Jing; Poorvi Kaushik; Qin He; Gordon Mills; David B Solit; Christine A Pratilas; Martin Weigt; Alfredo Braunstein; Andrea Pagnani; Riccardo Zecchina; Chris Sander
Journal:  PLoS Comput Biol       Date:  2013-12-19       Impact factor: 4.475

10.  Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.

Authors:  Elizabeth G Grubbs; Michelle D Williams; Paul Scheet; Selina Vattathil; Nancy D Perrier; Jeffrey E Lee; Robert F Gagel; Tao Hai; Lei Feng; Maria E Cabanillas; Gilbert J Cote
Journal:  Thyroid       Date:  2016-10-18       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.